Recent Research Articles
Fasting and Keto to Improve Cancer Treatment, Reduce Side Effects?
Does the published research on keto and fasting support this novel approach as a plausible standard of care to improve conventional therapy and reduce its often deleterious side effects?
A Clinician’s Perspective on Antioxidant Use During Chemotherapy for Breast Cancer: Exploring the Evidence
Master herbalist and clinical nutritionist Donnie Yance explores the research and shares his perspective on the use of botanicals and antioxidants during chemotherapy treatment for those with breast cancer.
Growing Value and Opportunity for Integrative Oncology in Hospital Settings
Listen to Glenn Sabin interviewed on the influential Relentless Health Value podcast on the topic of integrative oncology in hospital and health system settings. Host Stacey Richter and Glenn discuss the growing science supporting integrative oncology and the profound opportunity for hospitals and cancer centers to engage and educate their communities on true cancer prevention focused on smart lifestyle—read: beyond vaccines, colonoscopies, mammograms and early detection.
Chemo-Free Treatment Best Option for CLL Patients Under 70
There is good news in the advancement of chemo-free approaches to managing chronic lymphocytic leukemia, and I am thrilled to share it with you. Results of the phase III ECOG trial found that the combination of ibrutinib (Imbruvica) plus rituximab (Rituxan) came out superior to the chemotherapy and immunotherapy (chemoimmunotherapy) grouping of fludarabine, cyclophosphamide, and rituximab, known as FCR.
Cancer, Weed, CBD, and Me
Glenn shares how THC and CBD are being used in a clinical setting—and where we are in terms of current science supporting medical marijuana and CBD oil for symptom relief and as an anticancer agent. He also shares his own history with cannabinoids.
What Makes Exceptional Cancer Patients Exceptional?
Glenn explores the phenomena of cancer outliers, exceptional responders and radical remissions in the age of precision medicine, biomedical informatics and integrative oncology.
Does ‘Complementary Medicine’ in Cancer Care Cause Early Death?
A recently published paper in the esteemed JAMA Oncology triggered dire headlines, including this one in The New York Times:
“People who used herbs, acupuncture and other complementary treatments tended to die earlier than those who didn’t.”
Really? Is this true?
EWG: Our Best Resource To Inform Against Harmful Chemicals
For 20 years, the Environmental Working Group (EWG) has been the stalwart investigative organization scrutinizing unsafe chemicals and toxins in our food, water, cosmetics, and cleaning products.
Consumer-Direct Genetic Testing: ‘Consumer Power’ or ‘Grief’ Ahead?
Given the easy access to direct-to-consumer (DTC) DNA testing, it is vital to discern the potential value versus possible emotional and physical risks that having such data might present.
Microbiome’s Impact on Cancer Treatment: Strategies for a Healthy Gut
It is widely acknowledged that 80% of our immune system resides in our gut. Therefore, healthy microbiota—bio-diverse gut flora comprised of healthy strains of bacteria—may offer a powerful key to preventing disease, including cancer. Turns out, a healthy microbiome may also significantly enhance the treatment outcomes of anticancer agents, most notably novel targeted immunotherapies.
